Thoracic Meningioma Presenting with Progressive Lower Paraparesis in a Female Patient in Her 30’s
References
- Serratrice N, Lameche I, Attieh C, et al. Spinal meningiomas, from biology to management – A literature review. Front Oncol. 2023 Jan 13; 12:1084404. doi: 10.3389/fonc.2022.1084404.
- Sandalcioglu IE, Hunold A, Müller O, et al. Spinal meningiomas: critical review of 131 surgically treated patients. Eur Spine J. 2008 Aug;17(8):1035-41. doi: 10.1007/s00586-008-0685-y.
- Näslund O, Lipatnikova A, Dénes A, et al. Meningioma classification by immunohistochemistry: A replicability study. Brain Spine. 2022 Dec 27;3:101711. doi: 10.1016/j. bas.2022.101711.
- El-Hajj VG, Pettersson-Segerlind J, Fletcher-Sandersjöö A, et al. Current Knowledge on Spinal Meningiomas-Surgical Treatment, Complications, and Outcomes: A Systematic Review and Meta-Analysis (Part 2). Cancers (Basel). 2022 Dec 16;14(24):6221. doi: 10.3390/cancers14246221.
- Teranishi Y, Miyawaki S, Nakatochi M, et al. et al. Acta Neuropathol Commun. 2023 Sep 26;11(1):156. doi: 10.1186/s40478-023-01645-3.
- Tredway TL, Santiago P, Hrubes MR, et al. Minimally invasive resection of intradural-extramedullary spinal neoplasms. Neurosurgery. 2006 Feb;58(1 Suppl): ONS52-8; discussion ONS52-8. doi: 10.1227/01.neu.0000192661.08192.1c.
- Dang DD, Mugge LA, Awan OK, et al. Spinal Meningiomas: A Comprehensive Review and Update on Advancements in Molecular Characterization, Diagnostics, Surgical Approach and Technology, and Alternative Therapies. Cancers (Basel). 2024 Apr 7;16(7):1426. doi: 10.3390/cancers16071426.
- Caruso G, Ferrarotto R, Curcio A, et al. Novel Advances in Treatment of Meningiomas: Prognostic and Therapeutic Implications. Cancers (Basel). 2023 Sep 12;15(18):4521. doi: 10.3390/cancers15184521.
- Elsamadicy AA, Reeves BC, Craft S, et al. A current review of spinal meningiomas: epidemiology, clinical presentation and management. J Neurooncol. 2023 Jan;161(2):395-404. doi: 10.1007/s11060-023-04238-1.
- Jordan JT, Orr CC, Thalheimer RD, et al. Prospective phase II trial of the dual mTORC1/2 inhibitor vistusertib for progressive or symptomatic meningiomas in persons with neurofibromatosis 2. Neurooncol Adv. 2023 Apr 17;5(1):vdad041. doi: 10.1093/noajnl/vdad041.
- Bachir S, Shah S, Shapiro S, et al. Neurofibromatosis Type 2 (NF2) and the Implications for Vestibular Schwannoma and Meningioma Pathogenesis. Int J Mol Sci. 2021 Jan 12;22(2):690. doi: 10.3390/ijms22020690.
- El-Hajj VG, Pettersson-Segerlind J, Fletcher-Sandersjöö A, et al. Current Knowledge on Spinal Meningiomas – Surgical Treatment, Complications, and Outcomes: A Systematic Review and Meta-Analysis (Part 2). Cancers 2022, 14, 6221. https://doi.org/10.3390/cancers14246221
- Voldřich R, Netuka D, Beneš V. Spinal meningiomas: is Simpson grade II resection radical enough? Acta Neurochir (Wien). 2020 Jun;162(6):1401-1408. doi: 10.1007/s00701-020-04280-2.
- Lekanne Deprez RH, Bianchi AB, Groen NA, et al. Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas. Am J Hum Genet. 1994 Jun;54(6):1022-9.
- Brastianos PK, Twohy EL, Gerstner ER, et al. Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 Mutations. J Clin Oncol. 2023 Jan 20;41(3):618-628. doi: 10.1200/JCO.21.02371.
Language: English
Page range: 17 - 23
Submitted on: Aug 12, 2024
Accepted on: Oct 16, 2024
Published on: May 15, 2025
Published by: Sofia Medical University
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2025 K. Bechev, D. Markov, G. Markov, published by Sofia Medical University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.